Pfizer receives patent for pneumonia vaccine by Indian Patent Office

23 Aug 2017 Evaluate

Pfizer has been granted patent in India by the Indian Patent Office for its vaccine Prevenar 13, used for protection against pneumonia. The grant of the patent means that Indian pharmaceutical firms will not be able to make the vaccine.

The development has, however, been decried by Medicines Sans Frontiers (MSF), an international medical humanitarian organization saying granting patent on the vaccine could impact its availability.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4595.60 -127.70 (-2.70%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×